Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06017193 · ClinicalTrials.gov registry record
Ultrasound for Socket Healing Evaluation
A clinical trial of Dent Disease and Alveolar Bone Loss, sponsored by University of Michigan.
- Recruiting
- Registry status
- 140
- Enrollment target
- 1
- Study location
NCT06017193: Recruiting study of Dent Disease and Alveolar Bone Loss, sponsored by University of Michigan.
NCT06017193 is a study of Dent Disease and Alveolar Bone Loss that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 140 participants, below the 743-participant average among 4 other Dent Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06017193, a study of Dent Disease and Alveolar Bone Loss, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The design is a single blinded, dual comparative study of ultrasound versus micro-CT/LASCA in one study group. Up to a total of 140 subjects registered will be recruited. Subjects who are treatment planned for extraction of a hopeless tooth and socket augmentation with bone graft and are planned for a dental implant surgery. The socket will be evaluated before the extraction and multi-time points during healing until an implant is placed with various evaluation tools, including ultrasound.
Primary Outcome
To determine if bone graft maturation can be imaged by ultrasound. Bone healing by ultrasound will be given a scale and will be compared to the reference standard micro-computed tomography (micro-CT) of tissue core biopsy taken at implant surgery
Conditions Studied
Study Locations (1)
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2027-07-01 |
What NCT06017193 shows while recruiting
NCT06017193 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 743-participant average among 4 other Dent Disease trials with a reported enrollment target (81% lower).
The record links to 5 conditions, with Dent Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06017193 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06017193 about?
NCT06017193 is a clinical study titled "Ultrasound for Socket Healing Evaluation". The design is a single blinded, dual comparative study of ultrasound versus micro-CT/LASCA in one study group. Up to a total of 140 subjects registered will be recruited. Subjects who are treatment planned for extraction of a hopeless tooth and socket augmentation with bone graft and are planned for...
What is the current status of trial NCT06017193?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2024-07-25. Estimated completion is 2027-07-01.
What conditions does trial NCT06017193 study?
This clinical trial studies the following conditions: Dent Disease, Alveolar Bone Loss, Image, Healing Wound, Alveolar; Wound.
Who is sponsoring clinical trial NCT06017193?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06017193 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dent Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI